Did the obesity treatment ‘Belviq’ become a blockbuster product in 2 months since its launch?

The Ildong Pharmaceutical’s ambitious work, Belviq, has been unveiled. As a result, the news was that it has recorded KRW 5.3 billion sales in 2 months since its launch. However, it seems to look into a little more carefully to grasp the certainty.

It is explained that although a report of a financial company delivered sales of the Ildong’s products in the first quarter of the year, KRW 5.3 bi...